Toru Shimazui
Papers
2
Total Citations
50
H-Index
2
About
Toru Shimazui is a leading figure in urologic oncology, with a focused expertise in the surgical management of muscle-invasive bladder cancer. His primary research centers on advancing robot-assisted radical cystectomy (RARC), particularly through the integration of intracorporeal urinary diversion and neoadjuvant chemotherapy protocols. Shimazui’s major contribution lies in demonstrating the technical feasibility and oncologic safety of RARC as a minimally invasive alternative to traditional open surgery, showing that it can be performed effectively even after intensive chemotherapy. His most cited work, a 2019 study on RARC with intracorporeal diversion, has garnered 38 citations and helped establish this complex procedure as a viable standard. A subsequent 2016 study, with 12 citations, further validated the approach by comparing outcomes in patients receiving neoadjuvant treatment. Through these investigations, Shimazui has provided critical evidence that robotic techniques can reduce surgical morbidity without compromising cancer control, directly influencing clinical guidelines and expanding treatment options for patients with aggressive bladder tumors. His work continues to shape the evolution of minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2